Market Overview

UPDATE: Sterne Agee Upgrades athenahealth to Neutral; Overhang Removed

Related ATHN
New Survey Gives J.P. Morgan Confidence To Go Overweight Athenahealth, Allscripts & Advisory Board
Morning Market Losers
3 Industry Groups Show Strength, Rise Through Ranks (Investor's Business Daily)

Sterne Agee raised its rating on athenahealth (NASDAQ: ATHN) from Underperform to Neutral and increased its price target from $48.50 to $72.

Sterne Agee noted, "Contrary to our fears toward a significant air pocket in revenues created by the loss of a material channel partnership with PSS World Medical (PSSI, $28.48, NR), we now believe this relationship will continue. In hindsight, our industry checks had caused our view towards the ATHNPSSI partnership to become black and white, whereby we thought the partnership would end upon the consummation of PSSI's marriage with McKesson (MCK, $95.30, NR). We now believe McKesson will allow the PSS sales force the option to sell athena's solutions or MCK's solutions"

athenahealth closed at $73.89 on Friday.

Latest Ratings for ATHN

Nov 2015BarclaysDowngradesEqual-weightUnderweight
Nov 2015JP MorganAssumesOverweight
Oct 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

Posted-In: Sterne AgeeAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings


Related Articles (ATHN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters